相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aminobenzimidazoles and Structural Isomers as Templates for Dual-Acting Butyrylcholinesterase Inhibitors and hCB2R Ligands To Combat Neurodegenerative Disorders
Dominik Dolles et al.
CHEMMEDCHEM (2016)
Design and synthesis of potent and selective pyridazin-4(1H)-one-based PDE10A inhibitors interacting with Tyr683 in the PDE10A selectivity pocket
Masato Yoshikawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors
Sanath K. Meegalla et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia
Izzat T. Raheem et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Multitarget Drug Discovery and Polypharmacology
Maria Laura Bolognesi et al.
CHEMMEDCHEM (2016)
Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and in vitro evaluation of 1,8-dipyridinyl- and 1-pyridinyl-substituted imidazo[1,5-a]quinoxalines
Sally Wagner et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity
Anthony Knight et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength
Elena Segala et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A Real-World Perspective on Molecular Design
Bernd Kuhn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Graphene oxide: a reusable and metal-free carbocatalyst for the one-pot synthesis of 2-amino-3-cyanopyridines in water
Dariush Khalili
TETRAHEDRON LETTERS (2016)
Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies
Katarina Nikolic et al.
FRONTIERS IN NEUROSCIENCE (2016)
Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy
Anh T. N. Nguyen et al.
MOLECULAR PHARMACOLOGY (2016)
Experimental and theoretical studies of the nanostructured {Fe3O4@SiO2@(CH2)3Im}C(CN)3 catalyst for 2-amino-3-cyanopyridine preparation via an anomeric based oxidation
Mohammad Ali Zolfigol et al.
RSC ADVANCES (2016)
Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease
Flavia Niccolini et al.
BRAIN (2015)
Divergent Total Syntheses to Azafluoranthene and Dehydroaporphine Alkaloids
Nisachon Khunnawutmanotham et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2015)
Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells
Muhammad Khan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Data Warrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
Thomas Sander et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Design, Synthesis, and Pharmacological Evaluation of 5,6-Disubstituted Pyridin-2(1H)-one Derivatives as Phosphodiesterase 10A (PDE10A) Antagonists
V. S. Prasadarao Lingam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Identification of a Novel Orally Bioavailable Phosphodiesterase 10A (PDE10A) Inhibitor with Efficacy in Animal Models of Schizophrenia
Jose Manuel Bartolome-Nebreda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis
William D. Shipe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Iron(III) phosphate as a green and reusable catalyst for the synthesis of 4,6-disubstituted 2-aminopyridine-3-carbonitriles
Mahbobeh Zadpour et al.
MONATSHEFTE FUR CHEMIE (2015)
FAF-Drugs3: a web server for compound property calculation and chemical library design
David Lagorce et al.
NUCLEIC ACIDS RESEARCH (2015)
Target prediction utilising negative bioactivity data covering large chemical space
Lewis H. Mervin et al.
JOURNAL OF CHEMINFORMATICS (2015)
Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems
Ivano Amelio et al.
ONCOTARGET (2015)
Adenosine A2A Receptor as a Drug Discovery Target
Manuel de Lera Ruiz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Polypharmacology - Foe or Friend?
Jens-Uwe Peters
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Extensions to In Silico Bioactivity Predictions Using Pathway Annotations and Differential Pharmacology Analysis: Application to Xenopus laevis Phenotypic Readouts
Sonia Liggi et al.
MOLECULAR INFORMATICS (2013)
Discovery of potent, selective, and metabolically stable 4-(pyridin-3-yl)cinnolines as novel phosphodiesterase 10A (PDE10A) inhibitors
Essa Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Design and Characterization of Optimized Adenosine A2A/A1 Receptor Antagonists for the Treatment of Parkinson's Disease
Brian C. Shook et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions
Wei Liu et al.
SCIENCE (2012)
Ultrasound-promoted an efficient method for one-pot synthesis of 2-amino-4,6-diphenylnicotinonitriles in water: A rapid procedure without catalyst
Javad Safari et al.
ULTRASONICS SONOCHEMISTRY (2012)
Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration
Catarina V. Gomes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors
Jan Kehler et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones
Anna Drabczynska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Pyrimidine Derivatives as Potent and Selective A3 Adenosine Receptor Antagonists
Vicente Yaziji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Highly Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitors
Michael S. Malamas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
From in silico target prediction to multi-target drug design: Current databases, methods and applications
Alexios Koutsoukas et al.
JOURNAL OF PROTEOMICS (2011)
Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies
Richard J. Rickles et al.
BLOOD (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Assessment of the blood-brain barrier in CNS drug discovery
Phil Jeffrey et al.
NEUROBIOLOGY OF DISEASE (2010)
In-Silico Approaches to Multi-target Drug Discovery
Xiao Hua Ma et al.
PHARMACEUTICAL RESEARCH (2010)
Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors
Ashraf H. Abadi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008
Mayako Michino et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
Carmela Giampa et al.
NEUROBIOLOGY OF DISEASE (2009)
2-amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists
Monica Mantri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Preclinical characterization of selective phosphodiesterase 10A inhibitors: A new therapeutic approach to the treatment of schizophrenia
C. J. Schmidt et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist
Veli-Pekka Jaakola et al.
SCIENCE (2008)
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes
Chiara Bolcato et al.
PURINERGIC SIGNALLING (2008)
Epik:: a software program for pK a prediction and protonation state generation for drug-like molecules
John C. Shelley et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
Potent, selective, and orally active adenosine A2A receptor antagonists:: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
Bernard R. Neustadt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Application of multicomponent reactions to antimalarial drug discovery.: Part 2:: New antiplasmodial and antitrypanosomal 4-aminoquinoline γ- and δ-lactams via a 'catch and release' protocol
Chitalu C. Musonda et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Imidazoquinoxaline Src-family kinase p56Lck inhibitors:: SAR, QSAR, and the discovery of (S)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo[1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity
P Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
From magic bullets to designed multiple ligands
R Morphy et al.
DRUG DISCOVERY TODAY (2004)
Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor
MP Bosch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The application of multi-component reactions in drug discovery
L Weber
CURRENT MEDICINAL CHEMISTRY (2002)
Rational drug discovery: what can we learn from regulatory networks?
S Huang
DRUG DISCOVERY TODAY (2002)
Adenosine in the central nervous system: release mechanisms and extracellular concentrations
S Latini et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3β
MT Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
